statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Metagenomi, Inc. (Metagenomi or the Company...

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)

The law firm of Kirby McInerney LLP is investigating potential claims against Metagenomi, Inc. (Metagenomi or the Company) (NASDAQ: MGX). The investigation concerns whether Metagenomi and/or certain...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Metagenomi, Inc. (Metagenomi or the Company) (NASDAQ: MGX) investors concerning the Companys possible violations of federal...

The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Metagenomi, Inc. (Metagenomi or the Company) (NASDAQ: MGX) on behalf of investors concerning the Companys possible violations of federal...

Metagenomi, Inc. Expected to Earn FY2024 Earnings of ($2.44) Per Share (NASDAQ:MGX)

Metagenomi, Inc. (NASDAQ:MGX - Free Report) - Chardan Capital issued their FY2024 earnings estimates for Metagenomi in a note issued to investors on Monday, April 1st. Chardan Capital analyst G...

Chardan Capital Reaffirms Buy Rating for Metagenomi (NASDAQ:MGX)

Chardan Capital reaffirmed their buy rating on shares of Metagenomi (NASDAQ:MGX - Free Report) in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has...

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024 Proof...

Metagenomi, Inc.'s Quiet Period Will End  on March 20th (NASDAQ:MGX)

Metagenomis (NASDAQ:MGX  Get Free Report) quiet period will expire on Wednesday, March 20th. Metagenomi had issued 6,250,000 shares in its initial public offering on February 9th. The...

Metagenomi (NASDAQ:MGX) Now Covered by TD Cowen

TD Cowen assumed coverage on shares of Metagenomi (NASDAQ:MGX  Free Report) in a report released on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating on the stock...

Metagenomi initiated with bullish view at BMO Capital, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Volume	45,276.00
52-Wk High	$15.00
52-Wk Low	$3.34

MGX Metagenomi Inc.

About

Feed

News

Sentiment

Fundamentals